**Welwin Liu**

**VII**

[1] Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014; 13(7):700-709.

[10] Boerboom A, Dion V, Chariot A, Franzen R. Molecular mechanisms involved in schwann cell plasticity. Front Mol Neurosci. 2017;10:1-18.

[11] Jessen KR, Mirsky R. The success and failure of the schwann cell response to nerve injury. Front Cell Neurosci.

[12] Harty BL, Monk KR. Unwrapping the unappreciated: recent progress in Remak Schwann cell biology. Curr Opin

[13] Ioghen O, Manole E, Gherghiceanu M,. Popescu BO, Ceafalan LC.Nonmyelinating Schwann cells in health

[14] Hu D, Nicholls PK, Yin C, et al. Immunofluorescent localization of non-myelinating schwann cells and their interactions with immune cells in mouse thymus. J Histochem Cytochem

[15] Jones Hr Jr. Guillain-Barre syndrome: perspectives with infants and children. Semin Pediatr Neurol

[16] Solana-Rojas A, García-Melo LM, Reyes-Varela MD, et al. Recurrence of Guillain Barré Syndrome in patient paediatric with presentation of two different clinical variants. In this volume

[17] Mossberg N., Nordin M., Movitz C. et al. The recurrent Guillain Barré syndrome: a long-term population-based study, Acta Neurologica Scandinavica,

Neurobiol 2017; 47: 131–137.

and disease. In this volume.

2018; 66: 775–785.

2000; 7(2): 91-102.

vol. 2012;126: 154–161.

2005; 116:8–14.

[18] Korinthenberg R, Schessl J, Kirschner J, Mönting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial. Pediatrics

2019;13:1-14.

[2] Greenfield AL, Hauser SL. B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol. 2018; 83: 13–26.

Stroe AZ. Neuropsychiatric symptoms in demyelination disorders. In this

[4] Arnett PA, Higginson CI, Voss WD, Wright B, Bender WI, Wurst JM, et al. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology. 1999;13(3):434–446.

[5] Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafi ni G, et al. Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res. 2012; 73(6):411–417.

[6] Fishman I, Benedict RHB, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotic in multiple sclerosis. J Neuropsychiatry Clin Neurosci.

[7] Dalgas U, Stenager E, Ingemann-Hansen T, Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training; Multiple Sclerosis 2008; 14: 35–53.

[8] Wiszniewska K, Jaroszyk F, Opalko K, Wiszniewska M, Judo as an alternative rehabilitation method in multiple sclerosis. Fizjoterapia Polska

[9] Manole E, Bastian A, Oproiu AM, Isvoranu G. Schwann cell plasticity in peripheral nerve regeneration after

2004;16:350–356.

2019; 19(1), 30-36.

injury. In this volume

[3] Axelerad AD, Axelerad SD,

volume.

**References**

VA Pacific Islands Health Care System, United States of America
